Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry.
about
Glycosaminoglycan glycomics using mass spectrometryGlycReSoft: a software package for automated recognition of glycans from LC/MS dataDevelopment of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patientsEffect of heparin on the biological properties and molecular signature of human mesenchymal stem cellsUV-MALDI-TOF mass spectrometry analysis of heparin oligosaccharides obtained by nitrous acid controlled degradation and high performance anion exchange chromatography.Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometryModern developments in mass spectrometry of chondroitin and dermatan sulfate glycosaminoglycans.Targeted analysis of glycomics liquid chromatography/mass spectrometry data.Glycomics analysis of mammalian heparan sulfates modified by the human extracellular sulfatase HSulf2.Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractionsControl of organization and function of muscle and tendon by thrombospondin-4.Mass spectrometry and glycomicsLC-MS(n) analysis of isomeric chondroitin sulfate oligosaccharides using a chemical derivatization strategyTop-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS.Mass spectrometry and the emerging field of glycomics.On-line separations combined with MS for analysis of glycosaminoglycansHyphenated techniques for the analysis of heparin and heparan sulfate.Integrated Approach to Identify Heparan Sulfate Ligand Requirements of Robo1.Analysis of Glycosaminoglycans Using Mass Spectrometry.Improved hydrophilic interaction chromatography LC/MS of heparinoids using a chip with postcolumn makeup flow.A chip-based amide-HILIC LC/MS platform for glycosaminoglycan glycomics profiling.Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone-labeled disaccharides with LC-fluorescence and LC-MS detection.
P2860
Q26823079-9B5B7BC3-1363-4376-973F-F220E847D552Q30572721-ED21E25E-8F27-4BC3-82A0-B12DE1D35C3EQ33396321-2190418F-23AB-45CA-A4C4-44E5F2C6403DQ33426878-EA004839-570B-40C4-86F8-304782ADAF90Q33515199-BD37BD47-2E63-4C1D-90CB-7D00E4F57CF5Q33546538-E06F1E3E-9ACB-4AB4-B92D-1EE58130A560Q33633113-3D4493BB-4587-43D0-BAFF-54FBB88A45CAQ33720798-8ECB8DA1-353C-4383-823D-758ED72CB802Q33828849-88BD1389-B2C3-4DC8-ACAE-9F97CF30A1B1Q33864454-D0E52E3F-F0A2-48B5-A742-56411B190542Q34115854-8C9326C9-FFCD-4F7B-89C1-15730B9F025FQ35097817-6B6E473B-B5A9-478E-9ACD-CDE97367FA50Q35275665-A54CC2DD-37CA-4088-BCDE-38667FD77400Q36343123-EB17AF1D-A7FB-4396-9E48-EB84C5788E95Q37274089-512C42E9-13A2-42E4-8B3B-3F32C29F8BFBQ37310377-2C89B60A-619F-4D15-9EDE-1D7CB3799BB6Q37790317-D78D5610-BE8D-4D82-A188-B5411EDC545CQ38290964-6191BD47-2A39-4207-845E-94DC6286475AQ38338415-B40DB79E-D673-4440-B68D-41CE66F545F7Q40038320-C8C19460-6450-4E7F-B2CF-265DEF3F4EE5Q42100386-9663F32B-D939-46DD-8B9D-B01B53EFF27CQ53625004-F387F5B6-B0F9-440C-8AA3-7A97BC31C19E
P2860
Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Characterization of heparin ol ...... n III using mass spectrometry.
@ast
Characterization of heparin ol ...... n III using mass spectrometry.
@en
Characterization of heparin ol ...... n III using mass spectrometry.
@nl
type
label
Characterization of heparin ol ...... n III using mass spectrometry.
@ast
Characterization of heparin ol ...... n III using mass spectrometry.
@en
Characterization of heparin ol ...... n III using mass spectrometry.
@nl
prefLabel
Characterization of heparin ol ...... n III using mass spectrometry.
@ast
Characterization of heparin ol ...... n III using mass spectrometry.
@en
Characterization of heparin ol ...... n III using mass spectrometry.
@nl
P2093
P2860
P356
P1433
P1476
Characterization of heparin ol ...... n III using mass spectrometry.
@en
P2093
Hicham Naimy
Michael J Bowman
Nancy Leymarie
P2860
P304
P356
10.1021/BI702043E
P407
P50
P577
2008-02-09T00:00:00Z